A Phase III, Open-label, Randomized, Multi-center Study of the Effects of Leukocyte Interleukin, Injection (Multikine) Plus Standard of Care (Surgery + Radiotherapy or Surgery + Concurrent Chemoradiotherapy) in Subjects
|Effective start/end date||12/6/13 → 11/30/18|
- CEL-SCI CORPORATION
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.